Product ID |
Product Name |
CAS# |
Purity |
D593085 |
TD139 |
1450824-22-2 |
98% |
D593091 |
A-1331852 |
1430844-80-6 |
98% |
D593092 |
CZ415 |
1429639-50-8 |
98% |
D593094 |
GSK2578999A |
1422355-59-6 |
98% |
D593095 |
JNK-IN-7 |
1408064-71-0 |
98% |
D593104 |
Belizatinib (TSR011) |
1357920-84-3 |
98% |
D593121 |
GDC0326 |
1282514-88-8 |
98% |
D593133 |
GGTI298 |
1217457-86-7 |
98% |
D593135 |
LGH447 |
1210608-43-7 |
98% |
D593151 |
AT-2153 |
95604-83-4 |
98% |
D593153 |
LB-100 |
1632032-53-1 |
98% |
D593160 |
T-1095 |
209746-59-8 |
98% |
D593161 |
YM17690 |
108806-41-3 |
98% |
D593168 |
ON1231320 |
1312471-39-8 |
98% |
D593169 |
TAS-102 |
733030-01-8 |
98% |
D593170 |
Cyclosporin G |
74436-00-3 |
98% |
D597775 |
(1S)-7-methoxy-1,2,3,4-tetrahydronaphthalen-1-amine |
103791-17-9 |
95% |
D597794 |
(1S)-1-(2,3-DIMETHYLPHENYL)ETHYLAMINE-HCl |
1212991-78-0 |
>98% |
D597835 |
AMINO(3-BROMOPHENYL)ACETIC ACID |
150174-93-9 |
>98%; |
D597896 |
(2R)-2-amino-4,4,4-trifluorobutan-1-ol HCl |
1388797-83-8 |
>98% |
D597908 |
(S)-1-(4-ETHOXYPHENYL)ETHANAMINE-HCl |
1108684-07-6 |
97% |
D597941 |
(1S)-1-(4-HYDROIMIDAZO[1,2-A]PYRIDIN-6-YL)ETHYLAMINE HCl |
1259603-82-1 |
95% |
D597959 |
(R,E)-2-aminopent-3-en-1-ol HCl |
1932099-63-2 |
>98% |
D597960 |
(S,E)-2-aminopent-3-en-1-ol HCl |
1932371-98-6 |
>98% |
D597995 |
(1S)-1-(2-METHYLTHIOPHENYL)ETHYLAMINE-HCl |
|
>98% |
D597996 |
Ad2(n-Bu)P palladium(II) biphenyl-2-amine chloride 2nd Generation Ad2(n-Bu)P precatalyst |
|
>97% |
D597997 |
t-BuXPhos palladium(II) biphenyl-2-amine chloride 2nd Generation t-BuXPhos precatalyst |
|
>97% |
D597998 |
BrettPhos palladium(II) biphenyl-2-amine chloride 2nd Generation BrettPhos precatalyst |
|
>97% |
D598007 |
(S)-N-Fmoc-2-(6'-octenyl)glycine |
1058705-57-9 |
97% |
D598026 |
Fmoc-L-Arg(Pmc)- OH |
119831-72-0 |
>97% |
D598033 |
7-Octynoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-, (2S)- |
1198791-68-2 |
>97% |
D598034 |
7-Octynoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-, (2R)- |
1198791-69-3 |
>97% |
D598057 |
Fmoc-3-(1-Morpholinyl)-L-Ala-OH |
1251903-85-1 |
95% |
D598059 |
(S)-N-Fmoc-2-(5'-pentenyl)glycine |
1251904-51-4 |
97% |
D598088 |
(2S)-N-Fmoc-6-azido- hexanoic acid |
159610-89-6 |
98% |
D598133 |
(S)-N-Fmoc-2-(3'-butenyl)alanine |
288617-72-1 |
>97% |
D598149 |
2,5,7-Tris-tert-butyl-L-tryptophan |
62029-63-4 |
98% |
D598170 |
(2S)-N-Fmoc-4-azido-butanoic acid |
942518-20-9 |
98% |
D598171 |
5-Hexynoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)- |
942518-21-0 |
>97% |
D598180 |
Fmoc-D-Arg(Me, Me)-OH (symmetrical) |
|
>97% |
D598181 |
Fmoc-D-Arg(Me, Me)-OH (asymmetrical) |
|
>97% |
D598182 |
Fmoc-Lys(5,6 - FAM) - OH |
|
>97% |
D598188 |
5dR110 |
|
>97% |
D598189 |
5dR6G |
|
>97% |
D598190 |
Sulfo-Cy3-YNE |
1010386-62-5 |
98% |
D598197 |
Sulfo Cy7 Carboxylic acids(methyl) |
1251915-04-4 |
>97% |
D598218 |
NSP-DMAE-NHS |
194357-64-7 |
98% |
D598240 |
FAM alkyne, 5-isomer |
510758-19-7 |
>95% |
D598249 |
Sulfo-Cy3.5-SE |
|
>95% |
D598250 |
Sulfo-Cy5.5-SE |
|
>95% |
D598255 |
Sulfo-Cy5.5 alkyne |
|
>95% |
D598256 |
Sulfo-Cyanine7 alkyne |
2183440-55-1 |
>95% |
D598257 |
Cyanine7 alkyne |
|
>95% |
D598258 |
Cy5.5 alkyne |
1628790-37-3 |
>95% |
D598259 |
BDP FL alkyne |
302795-84-2 |
>95% |
D598264 |
Cy5 azide |
1782950-80-4 |
>95% |
D598265 |
Cy7 azide |
2183440-54-0 |
>95% |
D598266 |
Cy3 Maleimide |
|
>95% |
D598267 |
Sulfo Cy3 Maleimide |
|
>95% |
D598273 |
BODIPY TMR C5-Maleimide |
|
>95% |
D598274 |
EverFluor TMR C5-maleimide [Known as BODIPY TMR C5-maleimide, TM of Molecular Probes |
|
>95% |
D598275 |
Cy3 Amine |
2247688-56-6 |
>95% |
D598276 |
Sulfo Cy3 Amine |
|
>95% |
D598282 |
Sulfo-Cy3-SNAP-Tag |
|
>97% |
D598283 |
6 d ROX |
2507954-18-7 |
>97% |
D598284 |
5 d ROX |
2507954-16-5 |
>97% |
D598285 |
5-Alexa Fluor 488 5-SDP Ester |
|
>97% |
D598291 |
BODIPY FL Hydrazide |
|
>97% |
D598292 |
BODIPY R6G NHS Ester (Succinimidyl Ester) |
|
>97% |
D598293 |
Muscimol, BODIPY TMR-X Conjugate |
|
>97% |
D598294 |
BODIPY TMR-X NHS Ester (Succinimidyl Ester) |
|
>97% |
D598300 |
ER-Tracker Red (BODIPY TR Glibenclamide), for live-cell imaging |
|
>97% |
D598301 |
BODIPY 650/665-X NHS Ester (Succinimidyl Ester) |
|
>97% |
D598302 |
5(6)-Alexa Fluor 488 NHS Ester (Succinimidyl Ester) |
|
>97% |
D598303 |
5-Alexa Fluor 488 NHS Ester (Succinimidyl Ester) |
|
>97% |
D598311 |
5-Alexa Fluor 488 Cadaverine |
|
>97% |
D598312 |
6-Alexa Fluor 488 Cadaverine |
|
>97% |
D598313 |
5(6)-Alexa Fluor 488 Hydroxylamine |
|
>97% |
D598314 |
5-Alexa Fluor 488 Hydroxylamine |
|
>97% |
D598319 |
Alexa Fluor 488 Azide |
|
>97% |
D598320 |
Alexa Fluor 488 Alkyne |
|
>97% |
D583773 |
1H-Isoindole, 2,3-dihydro-5-(trifluoromethyl)-, hydrochloride |
924304-74-5 |
95% |
D583775 |
Acetyltransferase Inhibitor II |
932749-62-7 |
95% |
D583783 |
4-Methyl-6-trifluoromethyl-pyridin-3-ylamine |
944317-54-8 |
95% |
D583784 |
CAY10566 |
944808-88-2 |
95% |
D583793 |
2,3-Dihydrothieno[3,4-b][1,4]dioxine-2-carboxylic acid |
955373-67-8 |
95% |
D583799 |
2-ETHOXYPYRIMIDINE-5-BORONICACID |
1003043-55-7 |
95% |
D583800 |
2-CHLORO-5-FLUORO-3-NITRO-4-PICOLINE |
1003711-51-0 |
95% |
D583802 |
1H-Indol-5-aMine, 4-ethyl- |
1003858-71-6 |
95% |
D583807 |
EpigeneticMultipleLigand |
1020399-52-3 |
95% |
D583808 |
Chloro(2-dicyclohexylphosphino-2',6'-di-i-propoxy-1,1'-biphenyl)[2-(2-aminoethylphenyl)]palladium(II), methyl-t-butylether adduct, min. |
1028206-60-1 |
98% |
D583809 |
2,4-Thiazoledicarboxylic acid,4-(1,1-dimethylethyl) ester |
1029432-03-8 |
95% |
D583824 |
4-Amino-2-chloro-3-fluorobenzoic acid |
1124214-25-0 |
96% |
D583827 |
Methyl 3-broMo-4-cyclopropylbenzoate |
1131615-05-8 |
95% |
D583832 |
3,5-dichlorobenzyl piperazine-1-carboxylate |
1144037-37-5 |
95% |
D583836 |
RS-102895 hydrochloride |
1173022-16-6 |
95% |
D583861 |
4-BROMO-3-METHOXY-2-METHYLPYRIDINE |
1227592-47-3 |
95% |
D583862 |
2-PyriMidinaMine,4-Methyl-N-[5-Methyl-4-(1H-pyrazol-4-yl)-2-thiazolyl]- |
1235318-89-4 |
95% |
D583871 |
4-(4-broMo-1H-iMidazol-2-yl)pyridine |
1260682-35-6 |
95% |
D583872 |
4-(4-Acetylphenyl)Morpholin-3-One |
1260803-93-7 |
95% |